MARIYA TRIFONOVA: Open Payments
NPI 1063126191 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 40 payments from 12 companies in 2025. Trend: 2023 $669 · 2024 $841 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $190 |
| SCPHARMACEUTICALS INC. | 6 | $188 |
| Medtronic, Inc. | 1 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $101 |
| PFIZER INC. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Amgen Inc. | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $30 |
| Boston Scientific Corporation | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
Products named: LEQVIO, FUROSCIX, AURORA EV-ICD MRI SURESCAN, JARDIANCE, VYNDAQEL, Kerendia, REPATHA, LifeVest.
Industry payments across MD — which companies pay providers there.
